Outcome Capital has been following the pharma services market dynamics for the past 5 years. The authors believe that this fragmented segment will give way to greater consolidation by both financial buyers looking to roll up smaller players and larger contract research organizations seeking to expand into value-added specialty service areas. Adding to this consolidation is a tepid fund-raising environment, opening the door for financial buyers to play a role in consolidating many niche players.
Pharma Services Sector Poised for Continued Growth and ConsolidationPublished in PharmTech
Authors: Craig A. Steger, Thomas J. Joyce, and Oded Ben-Joseph
Abstract:
Outcome Capital has been following the pharma services market dynamics for the past 5 years. The authors believe that this fragmented segment will give way to greater consolidation by both financial buyers looking to roll up smaller players and larger contract research organizations seeking to expand into value-added specialty service areas. Adding to this consolidation is a tepid fund-raising environment, opening the door for financial buyers to play a role in consolidating many niche players.
Recent podcast conversation featuring Stanislav Glezer, Managing Director at Outcome Capital, on the ProjectMedtech Podcast, hosted by Duane Mancini.
Read More
Outcome Capital Life Science Market Pulse January 2026 Click to view our LifeSciences Pulse Newsletter
DownloadWould you like to learn more about working with Outcome Capital or discuss your specific needs?